Advancing Cardiovascular Care of the Oncology Patient

The Advancing Cardiovascular Care of the Oncology Patient course is now FULL. If you wish to have your name added to the waitlist, please contact ACC’s Resource Center at 800-253-4636, ext 5603.


In the United States, an estimated 14.5 million individuals have a history of cancer, representing a prevalent and rapidly growing population. Given this staggering statistic, clinicians often encounter patients with cancer and cancer survivors who have significant cardiovascular risk factors and cardiovascular disease.  The American College of Cardiology is offering this inaugural course, Advancing Cardiovascular Care of the Oncology Patient, to familiarize the clinical cardiology provider with key principles in cardio-oncology to support the increasing population of patients with cancer undergoing treatment or requiring survivorship care.  Join emerging pioneers in the field of cardio-oncology as they present, through interactive case discussions, debates, breakout sessions and roundtables, evidence-based treatment strategies that address pre, intra and post-chemotherapy heart health.

Learner Objectives

The overall goal of this course is to provide clinically relevant, state-of-the-art, best practice strategies in the assessment, diagnosis and management of cardiovascular concerns for patients with cancer and/or those requiring survivorship care.

Upon completion of this course, learners should be able to —

  • Identify risk factors for cardiotoxicity, including pre-existing heart disease and genetic factors, and the implications for cancer treatment
  • Recognize appropriate imaging modalities to assess cardiotoxicity, and distinguish the strengths and weaknesses of each cardiac monitoring modality, including echocardiography, strain, CT, MRI, and nuclear imaging
  • Incorporate guidelines from the cardiology and oncology societies into clinical practice
  • Identify the cardiovascular concerns with conventional and newer cancer therapies including the adverse effects manifestation timeline
  • Analyze the long term surveillance and management plan critical for patients who have received high risk systemic therapies such as anthracyclines and those treated with thoracic radiation
  • Identify optimal pharmacologic and lifestyle interventions to be instituted for cancer patients and survivors
  • Identify best practices when developing the cardio-oncology team to improve patient outcomes
  • Prepare at least two practice improvement business tactics such as referral process or coding 

Target Audience

The target audience is the cardiologist and cardiovascular advanced team members who are emerging into the field of cardio-oncology, specifically those providing clinical care to patients with cancer and cancer survivors with cardiac concerns.

Course Directors

Ana Barac, MD, PhD, FACC
Director, MedStar Heart and Vascular Institute
Medical Director, Cardiac Rehabilitation Program
Georgetown University
Washington, DC

Bonnie Ky, MD, MSCE, FACC
Assistant Professor of Medicine
Perelman School of Medicine at University of Pennsylvania

Content Expert

Anecita Fadol, PhD, RN, FNP, FAANP
Assistant Professor, Department of Nursing
The University of Texas MD Anderson Cancer Center
Houston TX

Nurse Planner

Kimberly V. Cheramie, MSN, RN-BC
Nurse Planner
American College of Cardiology
Washington, DC 

Invited Faculty

Saro Armenian, DO, MPH
Associate Professor, Departments of Pediatrics and Population Sciences
Director, Childhood Cancer Survivorship Clinic
Director, Division of Outcomes Research
Department of Population Sciences
City of Hope National Medical Center
Duarte, CA

Anita Arnold, DO, FACC, MBA/
Medical Director, Cardio-Oncology
Lee Health System
Associate Professor
Florida State University School of Medicine
Fort Myers, FL

Cathleen Biga, MSN, RN
President, Chief Executive Officer
Cardiovascular Management of Illinois
Woodridge, IL

Susan Dent, MD
Associate Professor
University of Ottawa
The Ottawa Hospital Cancer Centre
President, Canadian Cardiac Oncology Network
Ottawa ON  Canada

Jean-Bernard Durand, MD, FACC
Associate Professor
The University of Texas MD Anderson Cancer Center
Department of Cardiology

Matthew J. Ehrhardt, MD, MS
Research Associate
Division of Cancer Survivorship
St. June Children’s Research Hospital

Joerg Herrmann, MD
Associate Professor of Medicine
Mayo Clinic
Rochester, MN

W. Gregory Hundley, MD, FACC
Professor, Internal Medicine (Cardiology) and Radiology
Wake Forest University School of Medicine
Section of Cardiology
Winston Salem, NC

Monika Jacqueline Leja, MD, FACC
Clinical Assistant Professor
University of Michigan
Ann Arbor, MI

Daniel J. Lenihan, MD, FACC
Director, Clinical Research Program
Vanderbuilt Health
Professor of Medicine
Vanderbilt University

Jennifer E. Liu, MD, FACC
Memorial Sloan Kettering Cancer Center
New York 

Ileana L. Pina, MD, MPH, FACC
Associate Chief for Academic Affairs, Cardiology
Professor, Department of Medicine
Professor, Department of Epidemiology and Population Heath
Montefiore Medical Center
Bronx, NY

Mary Norine Walsh, MD, FACC
Medical Director, Heart Failure and Cardiac Transplantation
St. Vincent Heart Center of Indiana

Brendan M. Weiss, MD
Assistant Professor of Medicine
Director, Penn Amyloidosis Program
Abramson Cancer Center
Division of Hemaptology-Oncology
Hospital of the University of Pennsylvania

Ronald Witteles, MD, FACC
Associate Professor of Medicine
Stanford University School of Medicine
Stanford, CA

ACCF committee members, faculty, staff and other individuals who are in a position to control the content of this activity are required to disclose all relevant financial relationships he/she and/or his/her spouse or domestic partner has, occurring within the past twelve months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.  All relevant potential conflicts of interest that are identified are thoroughly vetted by course directors, ACCF education staff, and members of the Accreditation Compliance Workgroup through a process that includes appropriate peer review for fair balance, scientific objectivity and validity, and patient care and safety recommendations. Refer to the links below for committee member disclosures and course faculty disclosures. Please note ACCF staff involved with this course have nothing to disclose.

Faculty Disclosures


The Advancing Cardiovascular Care of the Oncology Patient course is now FULL. If you wish to have your name added to the waitlist, please contact ACC’s Resource Center at 800-253-4636, ext 5603.

If you have any special Dietary requirements, please note that this is now captured through your online profile. To enable us to accommodate your request, please ensure that your profile is up to date. If you select the (other) option, a member of our team will be in touch to discuss your needs. If you require assistance, please contact the Resource Center at 800-253-4636, ext. 5603.

Register me as: Designation Early Before 10/28/16
  Regular 10/29/16 Until 1/20/17
After 1/21/17 and Onsite
Member Physician (Includes International Associate) MD, DO, PhD $430 $530 $630
Non member Physician
MD, DO, PhD $650 $750 $850
Member Reduced (Includes CCA Members, CVT, Resident, Student and Emeritus)
PA, RN, NP, CNS, PharmD, Emeritus, Resident, Student
$285 $385 $485
Non-member Reduced
PA, RN, NP, CNS, PharmD $385 $485 $585

The registration tuition includes educational sessions, continental breakfasts, refreshment breaks, lunch and course materials.


Cancellation, substitution or transfer to another course is allowed if written notification is received four weeks before a scheduled course. A full refund minus a $250 processing fee will be given for written notifications received fewer than four weeks before the first day of the course. No refund will be given for no-shows.

ACC reserves the right to cancel the course in the unlikely event of insufficient enrollment or other unforeseen circumstances. If a course is canceled or postponed, ACC will refund registration tuition but cannot be held responsible for other costs or expenses, including cancellation/change penalties assessed by airlines, travel agencies or hotels.

The American College of Cardiology Foundation (ACCF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The ACCF designates this live activity for a maximum of 11.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

The ACCF designates this educational activity for a maximum of 11.25 continuing education hours.  Requirements for successful completion are attendance in a session in its entirety and completing the evaluation tool.

While offering credits noted above, the course is not intended to provide extensive training or certification in the field.

Learner Bill of Rights


All sessions will be held at the Park Hyatt Washington, 1201 24th Street, NW, Washington, DC.  The meeting site telephone number is 202-789-1234.


Our room block for this course reserved at the Park Hyatt Washington has sold out.  For those of you who still need to arrange for hotel accommodations while in Washington for the course February 17-18, we have secured an additional room block at The Fairmont, directly across the street from the Park Hyatt.  The negotiated rate at The Fairmont is the same as the negotiated rate at the Park Hyatt ($215 per room per night plus tax). 

If you wish to reserve a room at The Fairmont, below is information:

  • Call the Global Reservations Center at 800-441-1414; be sure to identify yourself with the American College of Cardiology’s Cardio-oncology course.  We will also offer you the ability to make your reservations through the Fairmont online system, available next week (check under the Travel tab AFTER January 6 for details)
  • Book soon; reservations must be made by January 27th to qualify for the group rate


Please Note
Smoking is prohibited in all ACC meeting rooms. 

We encourage participation by all individuals. If you have a disability, advance notification of any special needs will help us serve you better.

Faculty and course are subject to change without notice. 

Accredited status does not imply endorsement by the ANCC or ACC of any commercial products displayed in conjunction with this activity.

The views expressed in this course are those of the individual speaker and do not necessarily reflect the views of the ACC.

Clinical Topics: Cardio-Oncology

Keywords: Medical Oncology, Cardiotoxicity